SunTrust Banks Lowers Medidata Solutions (MDSO) to Hold

SunTrust Banks downgraded shares of Medidata Solutions (NASDAQ:MDSO) from a buy rating to a hold rating in a research report released on Wednesday, Briefing.com Automated Import reports. SunTrust Banks currently has $79.00 price target on the stock.

A number of other equities analysts have also commented on the stock. Wells Fargo & Co lowered shares of Medidata Solutions from an outperform rating to a market perform rating and set a $90.00 price objective for the company. in a research report on Tuesday, April 23rd. Guggenheim assumed coverage on shares of Medidata Solutions in a research report on Wednesday, April 17th. They issued a buy rating and a $92.00 price objective for the company. Zacks Investment Research lowered shares of Medidata Solutions from a hold rating to a sell rating in a research report on Tuesday, April 16th. William Blair assumed coverage on shares of Medidata Solutions in a research report on Monday, April 15th. They issued an outperform rating and a $74.93 price objective for the company. Finally, BidaskClub upgraded shares of Medidata Solutions from a buy rating to a strong-buy rating in a research report on Wednesday, March 20th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The company has an average rating of Hold and a consensus target price of $83.73.

MDSO stock opened at $89.42 on Wednesday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.71 and a quick ratio of 2.71. Medidata Solutions has a 12 month low of $60.10 and a 12 month high of $91.70. The company has a market capitalization of $5.57 billion, a PE ratio of 93.15, a PEG ratio of 6.07 and a beta of 1.35.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings data on Tuesday, February 12th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.08. Medidata Solutions had a net margin of 8.17% and a return on equity of 10.03%. The company had revenue of $167.19 million during the quarter, compared to analyst estimates of $168.08 million. During the same period last year, the business earned $0.41 earnings per share. Medidata Solutions’s revenue was up 18.1% compared to the same quarter last year. Equities research analysts predict that Medidata Solutions will post 0.8 EPS for the current year.

In other Medidata Solutions news, EVP Michael Pray sold 15,000 shares of Medidata Solutions stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $76.50, for a total transaction of $1,147,500.00. Following the completion of the sale, the executive vice president now directly owns 77,134 shares in the company, valued at $5,900,751. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Rouven Bergmann sold 12,512 shares of Medidata Solutions stock in a transaction that occurred on Wednesday, February 6th. The shares were sold at an average price of $75.00, for a total transaction of $938,400.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,237 shares of company stock valued at $3,568,628. 4.70% of the stock is currently owned by company insiders.

Institutional investors have recently made changes to their positions in the business. BlackRock Inc. raised its stake in shares of Medidata Solutions by 2.9% during the fourth quarter. BlackRock Inc. now owns 6,995,601 shares of the company’s stock worth $471,644,000 after acquiring an additional 195,763 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Medidata Solutions by 2.8% during the third quarter. Vanguard Group Inc. now owns 5,200,744 shares of the company’s stock worth $381,266,000 after acquiring an additional 142,687 shares in the last quarter. Vanguard Group Inc raised its stake in shares of Medidata Solutions by 2.8% during the third quarter. Vanguard Group Inc now owns 5,200,744 shares of the company’s stock worth $381,266,000 after acquiring an additional 142,687 shares in the last quarter. Clearbridge Investments LLC raised its stake in shares of Medidata Solutions by 5.9% during the third quarter. Clearbridge Investments LLC now owns 2,429,627 shares of the company’s stock worth $178,116,000 after acquiring an additional 135,078 shares in the last quarter. Finally, Canada Pension Plan Investment Board raised its stake in shares of Medidata Solutions by 1.3% during the fourth quarter. Canada Pension Plan Investment Board now owns 1,108,300 shares of the company’s stock worth $74,715,000 after acquiring an additional 13,700 shares in the last quarter.

Medidata Solutions Company Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Featured Article: Bull Market

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.